Pharmacovigilance and Safety Assessment

The session on Pharmacovigilance and Safety Assessment focuses on monitoring the safety and efficacy of medicinal plant-based products. Experts will discuss methodologies for adverse event reporting, risk assessment, and post-market surveillance. Discussions will encompass regulatory requirements, including reporting timelines and signal detection. Attendees can expect insights into the evaluation of potential herb-drug interactions and toxicity profiles. This session provides a critical platform for researchers, pharmacists, and regulatory professionals to exchange knowledge on ensuring the safe use of medicinal plant-based products, safeguarding public health while advancing the field of natural products in healthcare.

    Related Conference of Pharmacovigilance and Safety Assessment

    December 18-19, 2023

    3rd World Congress on Pain Medicine and Management

    London, UK
    March 18-19, 2024

    20th International Conference on Cancer Research

    Zurich, Switzerland
    April 24-25, 2024

    33rd Neonatology and Primary Care Congress

    Paris, France
    July 25-26, 2024

    20th World Summit on Blockchain Technology

    Amsterdam, Netherlands

    Pharmacovigilance and Safety Assessment Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in